A5020 — Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services.

A5020 — Prohibits pharmacy benefit manager from using spread pricing as model of prescription drug pricing; requires transparency in provision of pharmacy benefits management services. · Informed CitizenryThe legislation amends Section 3 of P.L.2023, c.107 by establishing several duties and requirements for carriers and pharmacy benefit managers (PBMs). A carrier contracting with a PBM must ensure t…Open in Informed Citizenry